The 2012 US Hemostasis Market

NEW YORK, April 19, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

The 2012 US Hemostasis Market

http://www.reportlinker.com/p0842779/The-2012-US-Hemostasis-Market.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic

Report Highlights

• Comprehensive 424-page analysis of the US hemostasis market.
• Major issues pertaining to the US hemostasis laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
• Ten-year volume and sales forecasts for 40 hemostasis procedures performed in US hospitals, commercial laboratories, and physician offices, including typical coagulation daily work loads. Table of Contents Introduction

  Worldwide Market and Technology Overview

  A. Major Routine and Special Hemostasis Tests

  1. Introduction

  2. Activated Partial Thromboplastin Time (APTT)

  3. Alpha-2 Antiplasmin

  4. Antithrombin III

  5. Bleeding Time

  6. D-Dimer

  7. Ethanol Flocculation Test

  8. Euglobulin Lysis

  9. Factor Assays

  a. Introduction

  b. Factor II

  c. Factor V/Factor V Leiden

  d. Factor VII

  e. Factor VIII

  f. Factor IX

  g. Factor IXa

  h. Factor X (Stuart Factor)

  i. Factor Xa

  j. Factor XI

  k. Factor XII

  l. Factor XIII

  10. Fibrin Degradation Products

  11. Fibrinogen

  12. Heparin

  13. Hirudin

  14. Hypercoagulability and Thrombosis

  15. Lipoprotein a

  16. Plasmin

  17. Plasminogen

  18. Plasminogen Activator Inhibitor (PAI)

  19. Platelet Function Tests

  20. Platelet Aggregation

  21. Proteins C and S

  22. Prothrombin Fragment 1.2

  23. Prothrombin Time (PT)

  24. Reptilase Time

  25. Thrombin Time

  26. Tissue-Type Plasminogen Activator (t-PA)

  27. Von Willebrand's Factor

  B. Instrumentation Review

  - Introduction

  - Benk Hemolab

  - Benk TRT Thrombotimer

  - Bio/Data MCA 310

  - Bio/Data MCA 210

  - Bio/Data PAP-4C D/4D/4C

  - Cardiovascular Diagnostics COAG

  - Diagnostica Stago STA Compact

  - Diagnostica Stago STA-R

  - Diagnostica Stago Star 4/8

  - Helena Laboratories Cascade 480

  - Helena Laboratories Cascade M

  - Helena Laboratories PACKS-4

  - Helena THOR

  - Instrumentation Laboratory ACL 100 and 1000 series

  - Instrumentation Laboratory ACL6000

  - Instrumentation Laboratory ACL7000

  - Instrumentation Laboratory ACL9000

  - Instrumentation Laboratory Electra 1000C

  - Instrumentation Laboratory Electra 1400C

  - Instrumentation Laboratory Electra 1600/C

  - Instrumentation Laboratory Electra 1800C

  - Instrumentation Laboratory Futura

  - ITC Hemochron 8000

  - Roche Diagnostics CoaguChek

  - Siemens BCS

  - Siemens BCT

  - Siemens BF II/Fibrintimer Series

  - Sysmex CA-50

  - Sysmex CA-500

  - Sysmex CA-1500

  - Sysmex CA-5000/CA-1000

  - Sysmex CA-6000

  - Sysmex CA-7000

  - Teco Coatron II/Jr./AccuStasis 5000

  - Trinity Biotech Amax CS190

  - Trinity Biotech Amax CS400

  - Trinity Biotech Coag-A-Mate Max

  - Trinity Biotech KC 40, 4A, 1A Series

  - Trinity Biotech MDA 180

  - Trinity Biotech Coag-A-Mate MTX

  - Trinity Biotech Coag-A-Mate RA4

  - Trinity Biotech Coag-A-Mate XC/Plus

  - Trinity Biotech Coag-A-Mate XM

  C. Major in Vitro Diagnostic Technologies and Their

  Potential Applications

  1. Chromogenic Substrates

  2. Monoclonal and Polyclonal Antibodies

  3. Immunoassays

  a. Applications

  b. Technological Principle

  c. Enzyme Immunoassays (EIA)

  - Overview

  - ELISA

  - EMIT

  - Dot Immunobinding Assays

  - Capillary Immunoassays

  - Enzyme Amplification

  - Electrochemical Immunoassay

  d. Fluorescent Immunoassays

  - Fluorescence Polarization

  - Time-Resolved Pulse Fluorescence

  - Fluorescence Lifetime

  e. Latex Agglutination

  f. Immunoprecipitation

  4. Microcomputers

  5. Automation

  6. Robotics

  7. DNA Probes

  a. Overview

  b. Amplification Methods

  - PCR

  - Ligase Chain Reaction

  - Branched DNA

  - Q-Beta Replicase

  - NASBA

  - SDA

  - 3 SR

  - HPA

  - Two-Tiered System

  - LAT

  8. Artificial Intelligence

  9. Dry Chemistry

  10. Biosensors

  D. Worldwide Market Overview

  1. Business Environment

  2. Market Structure

  3. Market Size and Growth

  4. POC Testing Market

  USA

  A. Executive Summary

  B. Business Environment

  1. Health Care Expenditures

  2. Cost Consciousness

  3. Industry Consolidation

  4. Managed Care

  5. Hospitals

  6. Admissions

  7. Length of Stay

  8. Industry Diversification

  9. Physician Demographics

  10. Population Aging

  a. Chronic Illnesses

  b. Disease Incidence

  c. Susceptibility to Iatrogenesis

  d. Multiple Illness Cases

  11. Laboratory Regulations

  C. Market Structure

  1. Centralized Testing

  a. Hospitals

  b. Commercial laboratories

  2. Decentralized Testing

  a. Physician Offices/Group Practices

  b. Point-of-Care Testing

  c. Home/Self Testing

  d. Other Decentralized Testing Locations

  D. Market Size, Growth And Major Suppliers

  Major Product Development Opportunities

  Design Criteria For Decentralized Testing Products

  Alternative Market Penetration Strategies

  A. Internal Development

  B. Collaborative Arrangements

  C. University Contracts

  D. Distribution Strategies for Decentralized Testing Markets

  1. Marketing Approaches

  2. Product Complexity

  3. Customer Preference

  4. Established Suppliers

  5. Emerging Suppliers

  6. Major Types Of Distributors

  7. Market Segmentation

  Potential Market Entry Barriers and Risks

  A. Market Maturity

  B. Cost Containment

  C. Competition

  D. Technological Edge and Limitations

  E. Patent Protection

  F. Regulatory Constraints

  G. Decentralized Testing Market Challenges

  Competitive Assessments

  - Abbott

  - American Diagnostica

  - Avocet Medical

  - Axis-Shield

  - Beckman Coulter

  - Becton Dickinson

  - Bio/Data Corporation

  - Biosite

  - Chrono-Log

  - Corgenix Medical

  - Diagnostica Stago

  - Helena Laboratories

  - HYPEN BioMed

  - Instrumentation Laboratory

  - ITC

  - Nanogen

  - Roche

  - Siemens

  - Sienco

  - Sysmex

  - Thermo Fischer

  - Trinity Biotech

  - ZyCare

  List of TablesMajor Companies Developing or Marketing Activated Clotting Time TestsMajor Companies Developing or Marketing APTT TestsMajor Companies Developing or Marketing Alpha-2 AntiplasminTestsMajor Companies Developing or Marketing Antithrombin III TestsMajor Companies Developing or Marketing Bleeding Time TestsMajor Companies Developing or Marketing D-dimer TestsMajor Companies Developing or Marketing Factor AssaysMajor Companies Developing or Marketing Fibrin DegradationProduct TestsMajor Companies Developing or Marketing Fibrinogen TestsMajor Companies Developing or Marketing Heparin TestsMajor Companies Developing or Marketing Plasmin TestsMajor Companies Developing or Marketing Plasminogen TestsMajor Companies Developing or Marketing Plasminogen ActivatorInhibitor TestsMajor Companies Developing or Marketing Platelet AggregationTestsMajor Companies Developing or Marketing Protein C TestsMajor Companies Developing or Marketing Protein S TestsMajor Companies Developing or Marketing PT TestsMajor Companies Developing or Marketing Thrombin Time TestsMajor Companies Developing or Marketing TPA TestsMajor Companies Developing or Marketing Von Willebrand'sFactor TestsWorldwide, All Market Segments, Laboratories PerformingHemostasis Tests By Country, 2010Worldwide, All Market Segments, Total Hemostasis Test VolumeBy Country, 2010-2020Worldwide, All Market Segments, Total Hemostasis ReagentMarket By Country, 2010-2020Worldwide, All Market Segments, Total Hemostasis InstrumentMarket By Country, 2010-2020Worldwide, All Market Segments, Total Hemostasis DiagnosticsMarket By Country, 2010-2020Executive Summary Table: U.S.A., Total Hemostasis DiagnosticsMarket By Market Segment and Product Category, 2010-2020U.S.A., Laboratories Performing Hemostasis Tests By MarketSegment, 2010U.S.A., Hospital Laboratories Performing Hemostasis Tests ByBed Size, 2010U.S.A., Commercial/Private Laboratories Performing HemostasisTests By Annual Test Volume, 2010U.S.A., Physician Offices/Group Practices Performing HemostasisTests By Practice Size, 2010U.S.A., Hospital Laboratories Average Daily Test Volume, 2010U.S.A., Commercial/Private Laboratories Average Daily TestVolume, 2010U.S.A., Physician Offices/Group Practices Average Daily TestVolumeU.S.A., Total Hemostasis Test Volume By Market Segment,2010-2020U.S.A., All Market Segments Hemostasis Test Volume, 2010-2020U.S.A., Hospital Laboratories Hemostasis Test Volume, 2010-2020U.S.A., Physician Offices/Group Practices Hemostasis Test Volume,2010-2020U.S.A., Commercial/Private Laboratories Hemostasis Test Volume,2010-2020U.S.A., Hemostasis Reagent Market By Market Segment,2010-2020U.S.A., Major Suppliers of Hemostasis Reagents EstimatedSales and Market Shares, 2010U.S.A., Hemostasis Instrument Market By Market Segment,2010-2020U.S.A., Major Suppliers of Hemostasis Analyzers, EstimatedTotal Instrument Placements and Market Shares, 2010U.S.A., Major Suppliers of Hemostasis Analyzers, EstimatedPlacements and Installed Base By Supplier and Model, 2010U.S.A., Major Suppliers of Hemostasis Analyzers, EstimatedInstrument Sales and Market Shares, 2010U.S.A., Total Hemostasis Diagnostics Market By ProductCategory, 2010-2020U.S.A., Major Suppliers of Hemostasis Diagnostic Products,Estimated Sales and Market Shares, 2010To order this report:In Vitro Diagnostic Industry: The 2012 US Hemostasis MarketMore  Market Research ReportCheck our  Industry Analysis and Insights

Nicolas Bombourg
Reportlinker
Email: [email protected]r.com
US: (805)652-2626
Intl: +1 805-652-2626

 

SOURCE Reportlinker